[go: up one dir, main page]

CN106266408A - A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method - Google Patents

A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method Download PDF

Info

Publication number
CN106266408A
CN106266408A CN201610938402.5A CN201610938402A CN106266408A CN 106266408 A CN106266408 A CN 106266408A CN 201610938402 A CN201610938402 A CN 201610938402A CN 106266408 A CN106266408 A CN 106266408A
Authority
CN
China
Prior art keywords
parts
radix
rhizoma
compound medicine
therapeutic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610938402.5A
Other languages
Chinese (zh)
Inventor
桑秋凌
尹维田
谭诚
姜志刚
李墨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin University
Original Assignee
Jilin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin University filed Critical Jilin University
Priority to CN201610938402.5A priority Critical patent/CN106266408A/en
Publication of CN106266408A publication Critical patent/CN106266408A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237Notopterygium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method, Huangqi Compound medicine is prepared from by the raw material of following weight portion: the Radix Astragali 50 70 parts, Radix Codonopsis 3 10 parts, 3 10 parts of Flos Carthami, Rhizoma Chuanxiong 3 10 parts, 2 10 parts of Poria, the Radix Angelicae Dahuricae 10 15 parts, Rhizoma Et Radix Notopterygii 15 parts, Cortex Magnoliae Officinalis 15 parts, the Rhizoma Atractylodis Macrocephalae 2 11 parts, Radix Rehmanniae 18 parts, Radix Bupleuri 16 parts, Rhizoma Cyperi 23 parts, Semen Raphani 18 parts, Radix Scutellariae 26 parts.Subject treatment method has the CO2 laser weld promoting damage, improves neuranagenesis quality characteristic, and prescription compatibility is reasonable, and methodological science determined curative effect is suitable in field of medicaments large-scale promotion.

Description

一种使用黄芪复方药物修复神经损伤治疗方法A treatment method for repairing nerve damage using Astragalus compound medicine

技术领域technical field

本发明属于医疗技术领域,具体涉及一种使用黄芪复方药物修复神经损伤治疗方法。The invention belongs to the technical field of medical treatment, and in particular relates to a treatment method for repairing nerve damage by using astragali compound medicine.

背景技术Background technique

周围神经损伤后,神经在损伤平面以下发生Wallerian变性,然后以每天1mm的速度再生。如何促进神经再生,提高神经再生质量,一直是医学界需要破解的难题。神经损伤后,积极有效的治疗是神经功能有效恢复的重要条件。对于神经纤维仍保持完整,神经失用型损伤,主要治疗手段是药物治疗;对于神经完全断裂或部分断裂的损伤、神经卡压所致的损伤,在神经缝合或松解之后的较长时间内需要配合药物治疗,为神经修复创造良好的内环境。现阶段临床常用的药物有维生素B族,神经生长因子、神经节苷脂等。与其它药物单一的作用机制不同,中药是一种多因素复合物,因有可能提供更丰富、比例更接近神经生理需求与生长活性因子的环境,而具有独特优势。After peripheral nerve injury, the nerve undergoes Wallerian degeneration below the level of injury, and then regenerates at a rate of 1mm per day. How to promote nerve regeneration and improve the quality of nerve regeneration has always been a difficult problem for the medical community to solve. After nerve injury, active and effective treatment is an important condition for the effective recovery of nerve function. For nerve fibers that remain intact and nerve disuse injuries, the main treatment is drug therapy; for injuries caused by complete or partial nerve rupture and nerve entrapment, within a long period of time after nerve suture or release It needs to cooperate with drug treatment to create a good internal environment for nerve repair. Drugs commonly used in clinical practice at this stage include vitamin B complex, nerve growth factor, ganglioside and so on. Different from the single action mechanism of other drugs, traditional Chinese medicine is a multi-factor complex, which has unique advantages because it may provide a richer environment with a ratio closer to neurophysiological needs and growth active factors.

因此发明一种新型的中药类复方药物用来修复神经损伤是非常有必要的。Therefore it is very necessary to invent a kind of novel traditional Chinese medicine compound medicine to be used for repairing nerve injury.

发明内容Contents of the invention

针对现有技术的不足,本发明提供了一种使用黄芪复方药物修复神经损伤治疗方法,可以有效快速进行神经损伤修复。Aiming at the deficiencies of the prior art, the present invention provides a treatment method for repairing nerve damage by using the astragalus compound drug, which can effectively and rapidly repair nerve damage.

为实现以上目的,本发明通过以下技术方案予以实现:本发明提供了一种使用黄芪复方药物修复神经损伤治疗方法,由以下重量份的原料制备而成:黄芪50-70份、党参3-10份、红花3-10份、川芎3-10份、茯苓2-10份、白芷10-15份、羌活1-5份、厚朴1-5份、白术2-11份、生地黄1-8份、柴胡1-6份、香附2-3份、莱菔子1-8份、黄芩2-6份;In order to achieve the above object, the present invention is achieved through the following technical solutions: the present invention provides a method for repairing nerve damage using the astragalus compound medicine, which is prepared from the following raw materials in parts by weight: 50-70 parts of Astragalus, 3-10 parts of Codonopsis 3-10 parts of safflower, 3-10 parts of Chuanxiong, 2-10 parts of Poria cocos, 10-15 parts of Angelica dahurica, 1-5 parts of notopterygium, 1-5 parts of Magnolia officinalis, 2-11 parts of Atractylodes macrocephala, 1-1 8 parts, 1-6 parts of Bupleurum, 2-3 parts of Rhizoma Cyperi, 1-8 parts of Radish Seed, 2-6 parts of Scutellaria baicalensis;

其治疗方法为:Its treatment method is:

(1)首先按处方重量份数称取茯苓与莱菔子混合,粉碎成极细粉(全部通过9号筛200目),得混合粉末A;(1) firstly take Poria cocos and raisin seed and mix by weight parts of the prescription, be ground into very fine powder (all pass through No. 9 sieve 200 meshes), get mixed powder A;

(2)按处方重量份数称取香附,粉碎后过2号至3号筛,将该粉末置挥发油提取器中,加入适量水,浸泡5-6小时,连续回流提取9-12小时,收集挥发油;(2) Weigh Cyperus cyperi according to the weight of the prescription, pass through No. 2 to No. 3 sieves after crushing, put the powder in a volatile oil extractor, add an appropriate amount of water, soak for 5-6 hours, and continuously reflux for 9-12 hours. collect volatile oil;

(3)按处方重量份数称取其余11味药材,分别单独粉碎,混合得总粉,加入适量乙醇溶液,加热回流提取5-8小时,冷却,过滤去除滤渣得滤液,滤液回收乙醇得浓缩浸膏B;(3) Weigh the remaining 11 medicinal materials according to the weight of the prescription, grind them separately, mix to obtain the total powder, add an appropriate amount of ethanol solution, heat and reflux for extraction for 5-8 hours, cool, filter and remove the filter residue to obtain the filtrate, and recover the ethanol from the filtrate to concentrate Extract B;

(4)最后将香附挥发油加入浓缩浸膏B中搅拌均匀,再将混合粉末A加入浓缩浸膏B中,充分搅拌均匀,得混合浸膏C(浓度2g/ml);(4) Finally, add Cyperus cyperi volatile oil into the concentrated extract B and stir evenly, then add the mixed powder A into the concentrated extract B, and stir well to obtain the mixed extract C (concentration 2g/ml);

(5)将步骤(4)制取的浸膏采用口服方式服用,一天两次,早上8:00-8:30灌胃一次,下午4:00-4:30灌胃一次,连续服用14天。(5) Take the extract prepared in step (4) orally, twice a day, once at 8:00-8:30 in the morning, and once at 4:00-4:30 in the afternoon, for 14 consecutive days .

优选地,所述的黄芪复方药物由以下重量份的原料制备而成:黄芪55-68份、川芎4-9份、党参4-10份、红花3-10份、茯苓3-8份、白芷10-15份、羌活2-4份、厚朴2-4份、白术4-10份、生地黄2-6份、柴胡2-5份、香附2-3份、莱菔子2-7份、黄芩2-6份。Preferably, the Astragalus compound medicine is prepared from the following raw materials in parts by weight: 55-68 parts of Astragalus, 4-9 parts of Rhizoma Chuanxiong, 4-10 parts of Codonopsis Codonopsis, 3-10 parts of Safflower, 3-8 parts of Poria cocos, 10-15 parts of Angelica dahurica, 2-4 parts of notopterygium, 2-4 parts of Magnolia officinalis, 4-10 parts of Atractylodes macrocephala, 2-6 parts of rehmannia root, 2-5 parts of Bupleurum, 2-3 parts of Rhizoma Cyperi, 2-3 parts of radish 7 parts, 2-6 parts of Radix Scutellariae.

优选地,所述的黄芪复方药物由以下重量份的原料制备而成:黄芪55份、党参4份、红花4份、川芎5份、茯苓4份、白芷5份、羌活3份、厚朴2份、白术6份、生地黄3份、柴胡2份、香附3份、莱菔子3份、黄芩3份。Preferably, the Astragalus compound drug is prepared from the following raw materials in parts by weight: 55 parts of Astragalus, 4 parts of Codonopsis, 4 parts of Safflower, 5 parts of Rhizoma Chuanxiong, 4 parts of Poria cocos, 5 parts of Angelica dahurica, 3 parts of Notopterygium, Magnolia officinalis 2 parts, 6 parts of Atractylodes macrocephala, 3 parts of Rehmannia glutinosa, 2 parts of Bupleurum, 3 parts of Cyperus cyperi, 3 parts of radish seed, and 3 parts of Scutellaria baicalensis.

优选地,所述的黄芪复方药物由以下重量份的原料制备而成:黄芪68份、党参5份、红花3份、川芎6份、茯苓5份、白芷6份、羌活2份、厚朴2份、白术7份、生地黄1份、柴胡3份、香附2份、莱菔子3份、黄芩3份。Preferably, the Astragalus compound drug is prepared from the following raw materials in parts by weight: 68 parts of Astragalus membranaceus, 5 parts of Codonopsis pilosula, 3 parts of safflower, 6 parts of Rhizoma Chuanxiong, 5 parts of Poria cocos, 6 parts of Angelica dahurica, 2 parts of notopterygium, Magnolia officinalis 2 parts, 7 parts of Atractylodes macrocephala, 1 part of rehmannia root, 3 parts of Bupleurum, 2 parts of Cyperus cyperi, 3 parts of radish seed, and 3 parts of skullcap.

优选的,所述的制备方法步骤(3)中乙醇溶液的相对浓度为70%。Preferably, the relative concentration of the ethanol solution in step (3) of the preparation method is 70%.

优选的,所述的制备方法步骤(4)中的均匀搅拌时间为30-50min。Preferably, the uniform stirring time in step (4) of the preparation method is 30-50 min.

本发明中各原料的功效如下:The effect of each raw material among the present invention is as follows:

黄芪:黄芪具有补气固表,利尿托毒,排脓,敛疮生肌的功效。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴。《本经》记载:“主痈疽,久败疮,排脓止痛。补虚,小儿百病。”《日华子本草》记载:“助气壮筋骨,长肉补血。Astragalus: Astragalus has the effects of invigorating qi and solidifying the surface, diuretic and detoxification, draining pus, astringing sores and promoting granulation. For qi deficiency and fatigue, lack of appetite, loose stools, subsidence of central qi, chronic diarrhea and prolapse of the anus, blood in the stool and metrorrhagia, spontaneous perspiration due to superficial deficiency, carbuncle and gangrene that are difficult to ulcerate, chronic ulceration without restraint, blood deficiency and chlorosis, internal heat and quenching thirst. "The Classic" records: "mainly carbuncle and gangrene, long-term sores, draining pus and relieving pain. Tonifies deficiency and treats all kinds of diseases in children." "Hanako Materia Medica" records: "Helps Qi and strengthens muscles and bones, grows flesh and nourishes blood.

党参:具有补中益气,健脾益肺之功效。党参有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用。此外对化疗放疗引起的白细胞下降有提升作用。Codonopsis: It has the effects of invigorating the middle and replenishing qi, invigorating the spleen and benefiting the lungs. Codonopsis pilosula has the effects of enhancing immunity, dilating blood vessels, lowering blood pressure, improving microcirculation, and enhancing hematopoietic function. In addition, it can improve the leukopenia caused by chemotherapy and radiotherapy.

红花:常与桃仁、当归、川芎、生地黄、赤芍药等同用,称为桃红四物汤。用于冠心病,可与川芎、丹参等同用。用于跌打损伤瘀血肿痛,瘀血肋痛,痈肿及吐血而有瘀滞者,可与桃仁、乳香、没药等同用。Safflower: often used with peach kernel, angelica, chuanxiong, rehmannia glutinosa, red peony, etc., called Taohong Siwu Decoction. For coronary heart disease, it can be used with Chuanxiong and Danshen. For bruises, swelling and pain due to blood stasis, costal pain due to blood stasis, carbuncle and hematemesis with stasis, it can be used with peach kernels, frankincense, and myrrh.

川芎:本品辛散温通,既能活血化瘀,又能行气止痛,为“血中之气药”,具通达气血功效,故治气滞血瘀之胸胁、腹部诸痛。Ligusticum Chuanxiong: This product is pungent and warm, can promote blood circulation and remove blood stasis, and can promote qi and relieve pain. It is a "qi medicine in blood" and has the effect of promoting qi and blood.

茯苓:性味味甘、淡,性平。归心、肺、脾、肾经。利水渗湿,健脾,宁心。主治用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。Poria cocos: sweet in taste, light in taste, flat in nature. Guixin, lung, spleen, kidney channel. Inducing diuresis to eliminate dampness, invigorating the spleen, calming the mind. Cure mainly for edema, oliguria, phlegm retention, dizziness and palpitation, deficiency of the spleen, lack of food, loose stool and diarrhea, restlessness, palpitation and insomnia.

白芷:性味辛,温。归经入肺、脾、胃经。功能主治祛风,燥湿,消肿,止痛。治头痛,眉棱骨痛,齿痛,鼻渊,寒湿腹痛,肠风痔漏,赤白带下,痈疽疮疡,皮肤燥痒,疥癣。Angelica dahurica: nature and flavor are pungent, warm. Return through entering lung, spleen, stomach meridian. Function cures mainly expelling wind, drying damp, detumescence, pain relieving. Cure headache, brow bone pain, toothache, nasal sinusitis, cold-damp abdominal pain, intestinal wind and hemorrhoids, red and white vaginal discharge, carbuncle sores, dry itchy skin, and scabies.

羌活:散表寒;祛风湿;利关节;止痛。主外感风寒;头痛无汗;油印寒湿痹;风水浮肿;疮疡肿毒。用于阳痿遗精,遗尿尿频,腰膝冷痛,肾虚作喘,五更泄泻;外用治白癜风,斑秃。解表散寒,祛风胜湿,止痛。Notopterygium: expelling exterior cold; expelling rheumatism; sharpening joints; relieving pain. Main exogenous wind-cold; headache without sweating; mimeograph cold-damp arthralgia; Fengshui edema; sore swollen toxin. For impotence and nocturnal emission, enuresis and frequent urination, cold pain in the waist and knees, asthma due to kidney deficiency, diarrhea at dawn; external use for treating vitiligo and alopecia areata. Relieve the exterior and dispel cold, expelling wind and dampness, relieving pain.

厚朴:味辛,性温;行气消积,燥湿除满,降逆平喘,主治食积气滞,腹胀便秘,湿阻中焦,脘痞吐泻,痰壅气逆,胸满喘咳。Magnolia officinalis: pungent in taste, warm in nature; promotes qi and eliminates stagnation, dries dampness and relieves fullness, subdues adverse events and relieves asthma, mainly treats food stagnation and stagnation of qi, abdominal distension and constipation, dampness resistance in the middle burner, nausea and vomiting, phlegm stagnation and qi reversal, chest fullness and coughing .

白术:以根茎入药。燥湿健脾,脾虚食少,消化不良,慢性腹泻、水肿、止汗,安胎。Atractylodes macrocephala: use the rhizome as medicine. Dry dampness and invigorate the spleen, insufficiency of the spleen, lack of food, indigestion, chronic diarrhea, edema, antiperspirant, and antifertility.

生地黄:鲜地黄清热生津,凉后,止血;用于热风伤阴、舌绛烦渴、发斑发疹、吐血、衄血、咽喉肿痛。生地黄清热凉血,养阴,生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血、糖尿病、传染性肝炎。。Rehmannia glutinosa: Fresh rehmannia glutinosa clears away heat and promotes body fluid, and stops bleeding after cooling; it is used for hot wind hurting yin, crimson tongue and polydipsia, spots and rashes, hematemesis, epistaxis, and sore throat. Radix Rehmanniae clears away heat and cools blood, nourishes yin, and promotes body fluid; it is used for fever, polydipsia, spot rash, internal heat due to yin deficiency, hematemesis, epistaxis, diabetes, and infectious hepatitis. .

柴胡:性味苦、微寒,归肝、胆经。有和解表里,疏肝升阳之功效。用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱垂、月经不调。Bupleurum: bitter in nature and flavor, slightly cold, returns to the liver and gallbladder meridians. It has the effects of reconciling the exterior and interior, soothing the liver and promoting yang. For cold and fever, alternating cold and heat, malaria, liver depression and Qi stagnation, sternocostal pain, anal prolapse, uterine prolapse, and irregular menstruation.

香附:苦,寒。归肺、肝、心经;解毒消肿:用于咽喉肿痛、疮疡肿痛等;止咳化痰:用于咳嗽痰多,肺热咳喘,咯痰黄稠等。Rhizoma Cyperae: bitter, cold. Return lung, liver, heart meridian; detoxify and reduce swelling: used for sore throat, sore swelling and pain, etc.; relieving cough and reducing phlegm: used for cough with excessive phlegm, cough with lung heat, thick yellow phlegm, etc.

莱菔子:莱菔子具有消食,理气,化痰,止咳,清肺利咽,散瘀消肿的功效。主治食积气滞,脘腹痞满,吐酸,呃逆,泄泻,痢疾,咽喉肿痛,咳痰,音哑,妇女乳房肿痛,乳汁不通,外治损伤瘀肿等症。Radix Seed: Radix Seed has the effects of eliminating food, regulating qi, reducing phlegm, relieving cough, clearing lung and relieving throat, dissipating blood stasis and reducing swelling. Indications for stagnation of Qi due to food accumulation, fullness in the abdomen, acid regurgitation, hiccups, diarrhea, dysentery, sore throat, coughing up phlegm, hoarseness, breast swelling and pain in women, milk blockage, external treatment injury and bruising embolism.

黄芩:以根入药有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。Scutellaria baicalensis: the root is used as medicine to clear away heat and dampness, cool blood and induce miscarriage, and detoxify. Indications for febrile disease, upper respiratory tract infection, lung-heat cough, damp-heat jaundice, pneumonia, dysentery, hemoptysis, red eyes, restless fetus, high blood pressure, carbuncle, swollen boils and other diseases.

本发明有益效果:Beneficial effects of the present invention:

本发明所采用的黄芪复方药物将各原料药物科学配伍,共奏之效,治疗药物制备方法简便实用,配合治疗方法,将药物采用灌胃的方式对病体进行治疗,具有促进损伤的神经修复,提高神经再生质量特点,组方配伍合理,方法科学,疗效确切,适合在医药领域大规模推广。The Radix Astragali compound drug used in the present invention is scientifically compatible with various raw materials to achieve the same effect. The preparation method of the therapeutic drug is simple and practical. In combination with the treatment method, the drug is used to treat the disease body by gavage, which can promote the repair of damaged nerves. The characteristics of improving the quality of nerve regeneration, the composition of the prescription is reasonable, the method is scientific, the curative effect is definite, and it is suitable for large-scale promotion in the field of medicine.

具体实施方式detailed description

为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明的实施例,对本发明实施例中的技术方案进行清楚、完整地描述。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention more clear, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

实施例1:Example 1:

一种使用黄芪复方药物修复神经损伤治疗方法,黄芪复方药物由以下重量份的原料制备而成:黄芪50份、党参4份、红花3份、川芎3份、茯苓2份、白芷5份、羌活1份、厚朴1份、白术2份、生地黄1份、柴胡1份、香附2份、莱菔子1份、黄芩2份。The invention discloses a method for treating nerve damage by using the Astragalus compound medicine. The Astragalus compound medicine is prepared from the following raw materials in parts by weight: 50 parts of Astragalus membranaceus, 4 parts of Codonopsis pilosula, 3 parts of safflower, 3 parts of Rhizoma Chuanxiong, 2 parts of Poria cocos, 5 parts of Angelica dahurica, Notopterygium 1 part, Magnolia officinalis 1 part, Atractylodes macrocephala 2 parts, Rehmannia glutinosa 1 part, Bupleurum 1 part, Cyperus cyperi 2 parts, radish seed 1 part, Scutellaria baicalensis 2 parts.

其治疗方法为:Its treatment method is:

(1)首先按处方重量份数称取茯苓与莱菔子混合,粉碎成极细粉(全部通过9号筛200目),得混合粉末A;(1) firstly take Poria cocos and raisin seed and mix by weight parts of the prescription, be ground into very fine powder (all pass through No. 9 sieve 200 meshes), get mixed powder A;

(2)按处方重量份数称取香附,粉碎后过2号至3号筛,将该粉末置挥发油提取器中,加入适量水,浸泡5小时,连续回流提取9小时,收集挥发油;(2) Cyperi cyperi was weighed in parts by weight of the prescription, crushed and passed through No. 2 to No. 3 sieves, the powder was placed in a volatile oil extractor, an appropriate amount of water was added, soaked for 5 hours, continuously refluxed for 9 hours, and the volatile oil was collected;

(3)按处方重量份数称取其余11味药材,分别单独粉碎,混合得总粉,加入相对浓度为70%的乙醇溶液,加热回流提取5小时,冷却,过滤去除滤渣得滤液,滤液回收乙醇得浓缩浸膏B;(3) Weigh the remaining 11 medicinal materials according to the weight of the prescription, grind them separately, mix them to obtain a total powder, add an ethanol solution with a relative concentration of 70%, heat and reflux for extraction for 5 hours, cool, filter and remove the filter residue to obtain a filtrate, and recover the filtrate Ethanol to obtain concentrated extract B;

(4)最后将香附挥发油加入浓缩浸膏B中搅拌均匀30min,再将混合粉末A加入浓缩浸膏B中,充分搅拌均匀,得混合浸膏C(浓度2g/ml);(4) Finally, add Cyperus cyperi volatile oil into the concentrated extract B and stir evenly for 30 minutes, then add the mixed powder A into the concentrated extract B, and stir well to obtain the mixed extract C (concentration 2g/ml);

(5)将步骤(4)制取的浸膏采用口服方式服用,一天两次,早上8:00-8:30灌胃一次,下午4:00-4:30灌胃一次,连续服用14天。(5) Take the extract prepared in step (4) orally, twice a day, once at 8:00-8:30 in the morning, and once at 4:00-4:30 in the afternoon, for 14 consecutive days .

实施例2:Example 2:

一种使用黄芪复方药物修复神经损伤治疗方法,黄芪复方药物由以下重量份的原料制备而成:黄芪70份、党参8份、红花3份、川芎4份、茯苓3份、白芷5份、羌活2份、厚朴2份、白术4份、生地黄2份、柴胡2份、香附2份、莱菔子2份、黄芩6份。The invention discloses a method for treating nerve damage by using compound Astragalus medicaments. The compound Astragalus medicaments are prepared from the following raw materials in parts by weight: 70 parts of Astragalus membranaceus, 8 parts of Codonopsis pilosula, 3 parts of safflower, 4 parts of Rhizoma Chuanxiong, 3 parts of Poria cocos, 5 parts of Angelica dahurica, Notopterygium 2 parts, Magnolia officinalis 2 parts, Atractylodes macrocephala 4 parts, Rehmannia glutinosa 2 parts, Bupleurum 2 parts, Cyperus cyperi 2 parts, Laifuzi 2 parts, Scutellaria baicalensis 6 parts.

其治疗方法为:Its treatment method is:

(1)首先按处方重量份数称取茯苓与莱菔子混合,粉碎成极细粉(全部通过9号筛200目),得混合粉末A;(1) firstly take Poria cocos and raisin seed and mix by weight parts of the prescription, be ground into very fine powder (all pass through No. 9 sieve 200 meshes), get mixed powder A;

(2)按处方重量份数称取香附,粉碎后过2号至3号筛,将该粉末置挥发油提取器中,加入适量水,浸泡6小时,连续回流提取12小时,收集挥发油;(2) Cyperi cyperi was weighed in parts by weight of the prescription, crushed and passed through No. 2 to No. 3 sieves, the powder was placed in a volatile oil extractor, an appropriate amount of water was added, soaked for 6 hours, continuously refluxed for 12 hours, and the volatile oil was collected;

(3)按处方重量份数称取其余11味药材,分别单独粉碎,混合得总粉,加入相对浓度为70%的乙醇溶液,加热回流提取8小时,冷却,过滤去除滤渣得滤液,滤液回收乙醇得浓缩浸膏B;(3) Weigh the remaining 11 medicinal materials according to the weight of the prescription, grind them separately, mix to obtain the total powder, add ethanol solution with a relative concentration of 70%, heat and reflux for extraction for 8 hours, cool, filter and remove the filter residue to obtain the filtrate, and recover the filtrate Ethanol to obtain concentrated extract B;

(4)最后将香附挥发油加入浓缩浸膏B中搅拌均匀50min,再将混合粉末A加入浓缩浸膏B中,充分搅拌均匀,得混合浸膏C(浓度2g/ml);(4) Finally, add Cyperus cyperi volatile oil into the concentrated extract B and stir evenly for 50 minutes, then add the mixed powder A into the concentrated extract B, and stir well to obtain the mixed extract C (concentration 2g/ml);

(5)将步骤(4)制取的浸膏采用口服方式服用,一天两次,早上8:00-8:30灌胃一次,下午4:00-4:30灌胃一次,连续服用14天。(5) Take the extract prepared in step (4) orally, twice a day, once at 8:00-8:30 in the morning, and once at 4:00-4:30 in the afternoon, for 14 consecutive days .

实施例3:Example 3:

一种使用黄芪复方药物修复神经损伤治疗方法,黄芪复方药物由以下重量份的原料制备而成:黄芪55份、党参6份、红花8份、川芎4份、茯苓3份、白芷5份、羌活2份、厚朴2份、白术4份、生地黄2份、柴胡2份、香附2份、莱菔子2份、黄芩2份。The invention discloses a method for treating nerve damage by using the Astragalus compound medicine. The Astragalus compound medicine is prepared from the following raw materials in parts by weight: 55 parts of Astragalus membranaceus, 6 parts of Codonopsis pilosula, 8 parts of safflower, 4 parts of Rhizoma Chuanxiong, 3 parts of Poria cocos, 5 parts of Angelica dahurica, Notopterygium 2 parts, Magnolia officinalis 2 parts, Atractylodes macrocephala 4 parts, Rehmannia glutinosa 2 parts, Bupleurum 2 parts, Cyperus cyperi 2 parts, Laifuzi 2 parts, Scutellaria baicalensis 2 parts.

其治疗方法为:Its treatment method is:

(1)首先按处方重量份数称取茯苓与莱菔子混合,粉碎成极细粉(全部通过9号筛200目),得混合粉末A;(1) firstly take Poria cocos and raisin seed and mix by weight parts of the prescription, be ground into very fine powder (all pass through No. 9 sieve 200 meshes), get mixed powder A;

(2)按处方重量份数称取香附,粉碎后过2号至3号筛,将该粉末置挥发油提取器中,加入适量水,浸泡6小时,连续回流提取10小时,收集挥发油;(2) Cyperi cyperi was weighed in parts by weight of the prescription, crushed and passed through No. 2 to No. 3 sieves, the powder was placed in a volatile oil extractor, an appropriate amount of water was added, soaked for 6 hours, continuously refluxed for 10 hours, and the volatile oil was collected;

(3)按处方重量份数称取其余11味药材,分别单独粉碎,混合得总粉,加入相对浓度为70%的乙醇溶液,加热回流提取6小时,冷却,过滤去除滤渣得滤液,滤液回收乙醇得浓缩浸膏B;(3) Weigh the remaining 11 medicinal materials according to the weight of the prescription, grind them separately, mix them to obtain the total powder, add an ethanol solution with a relative concentration of 70%, heat and reflux for extraction for 6 hours, cool, filter and remove the filter residue to obtain a filtrate, and recover the filtrate Ethanol to obtain concentrated extract B;

(4)最后将香附挥发油加入浓缩浸膏B中搅拌均匀40min,再将混合粉末A加入浓缩浸膏B中,充分搅拌均匀,得混合浸膏C(浓度2g/ml);(4) Finally, add Cyperus cyperi volatile oil into the concentrated extract B and stir evenly for 40 minutes, then add the mixed powder A into the concentrated extract B, and stir well to obtain the mixed extract C (concentration 2g/ml);

(5)将步骤(4)制取的浸膏采用口服方式服用,一天两次,早上8:00-8:30灌胃一次,下午4:00-4:30灌胃一次,连续服用14天。(5) Take the extract prepared in step (4) orally, twice a day, once at 8:00-8:30 in the morning, and once at 4:00-4:30 in the afternoon, for 14 consecutive days .

实施例4:Example 4:

一种使用黄芪复方药物修复神经损伤治疗方法,黄芪复方药物由以下重量份的原料制备而成:黄芪68份、党参5份、红花6份、川芎5份、茯苓4份、白芷5份、羌活3份、厚朴2份、白术6份、生地黄3份、柴胡2份、香附3份、莱菔子3份、黄芩3份。The invention discloses a method for treating nerve damage by using a compound medicine of Astragalus membranaceus. The compound medicine of Astragalus membranaceus is prepared from the following raw materials in parts by weight: 68 parts of Astragalus membranaceus, 5 parts of Codonopsis pilosula, 6 parts of safflower, 5 parts of Chuanxiong, 4 parts of Poria cocos, 5 parts of Angelica dahurica, Notopterygium 3 parts, Magnolia officinalis 2 parts, Atractylodes macrocephala 6 parts, Rehmannia glutinosa 3 parts, Bupleurum 2 parts, Cyperus cyperi 3 parts, Laifuzi 3 parts, Scutellaria baicalensis 3 parts.

其治疗方法为:Its treatment method is:

(1)首先按处方重量份数称取茯苓与莱菔子混合,粉碎成极细粉(全部通过9号筛200目),得混合粉末A;(1) firstly take Poria cocos and raisin seed and mix by weight parts of the prescription, be ground into very fine powder (all pass through No. 9 sieve 200 meshes), get mixed powder A;

(2)按处方重量份数称取香附,粉碎后过2号至3号筛,将该粉末置挥发油提取器中,加入适量水,浸泡5小时,连续回流提取10小时,收集挥发油;(2) Cyperi cyperi was weighed in parts by weight of the prescription, crushed and passed through No. 2 to No. 3 sieves, the powder was placed in a volatile oil extractor, an appropriate amount of water was added, soaked for 5 hours, and continuously refluxed for 10 hours to collect the volatile oil;

(3)按处方重量份数称取其余11味药材,分别单独粉碎,混合得总粉,加入相对浓度为70%的乙醇溶液,加热回流提取6小时,冷却,过滤去除滤渣得滤液,滤液回收乙醇得浓缩浸膏B;(3) Weigh the remaining 11 medicinal materials according to the weight of the prescription, grind them separately, mix them to obtain the total powder, add an ethanol solution with a relative concentration of 70%, heat and reflux for extraction for 6 hours, cool, filter and remove the filter residue to obtain a filtrate, and recover the filtrate Ethanol to obtain concentrated extract B;

(4)最后将香附挥发油加入浓缩浸膏B中搅拌均匀40min,再将混合粉末A加入浓缩浸膏B中,充分搅拌均匀,得混合浸膏C(浓度2g/ml);(4) Finally, add Cyperus cyperi volatile oil into the concentrated extract B and stir evenly for 40 minutes, then add the mixed powder A into the concentrated extract B, and stir well to obtain the mixed extract C (concentration 2g/ml);

(5)将步骤(4)制取的浸膏采用口服方式服用,一天两次,早上8:00-8:30灌胃一次,下午4:00-4:30灌胃一次,连续服用14天。(5) Take the extract prepared in step (4) orally, twice a day, once at 8:00-8:30 in the morning, and once at 4:00-4:30 in the afternoon, for 14 consecutive days .

实施例5:Example 5:

一种使用黄芪复方药物修复神经损伤治疗方法,黄芪复方药物由以下重量份的原料制备而成:黄芪65份、党参10份、红花4份、川芎6份、茯苓5份、白芷6份、羌活2份、厚朴2份、白术7份、生地黄1份、柴胡3份、香附2份、莱菔子3份、黄芩3份。The invention discloses a method for treating nerve damage by using compound Astragali medicaments. The compound Astragalus medicaments are prepared from the following raw materials in parts by weight: 65 parts of Astragalus membranaceus, 10 parts of Codonopsis pilosula, 4 parts of safflower, 6 parts of Chuanxiong, 5 parts of Poria cocos, 6 parts of Angelica dahurica, 2 parts of notopterygium, 2 parts of Magnolia officinalis, 7 parts of Atractylodes macrocephala, 1 part of rehmannia root, 3 parts of Bupleurum, 2 parts of Cyperus cyperi, 3 parts of radish seed, and 3 parts of skullcap.

其治疗方法为:Its treatment method is:

(1)首先按处方重量份数称取茯苓与莱菔子混合,粉碎成极细粉(全部通过9号筛200目),得混合粉末A;(1) firstly take Poria cocos and raisin seed and mix by weight parts of the prescription, be ground into very fine powder (all pass through No. 9 sieve 200 meshes), get mixed powder A;

(2)按处方重量份数称取香附,粉碎后过2号至3号筛,将该粉末置挥发油提取器中,加入适量水,浸泡5小时,连续回流提取10小时,收集挥发油;(2) Cyperi cyperi was weighed in parts by weight of the prescription, crushed and passed through No. 2 to No. 3 sieves, the powder was placed in a volatile oil extractor, an appropriate amount of water was added, soaked for 5 hours, and continuously refluxed for 10 hours to collect the volatile oil;

(3)按处方重量份数称取其余11味药材,分别单独粉碎,混合得总粉,加入相对浓度为70%的乙醇溶液,加热回流提取6小时,冷却,过滤去除滤渣得滤液,滤液回收乙醇得浓缩浸膏B;(3) Weigh the remaining 11 medicinal materials according to the weight of the prescription, grind them separately, mix them to obtain the total powder, add an ethanol solution with a relative concentration of 70%, heat and reflux for extraction for 6 hours, cool, filter and remove the filter residue to obtain a filtrate, and recover the filtrate Ethanol to obtain concentrated extract B;

(4)最后将香附挥发油加入浓缩浸膏B中搅拌均匀40min,再将混合粉末A加入浓缩浸膏B中,充分搅拌均匀,得混合浸膏C(浓度2g/ml);(4) Finally, add Cyperus cyperi volatile oil into the concentrated extract B and stir evenly for 40 minutes, then add the mixed powder A into the concentrated extract B, and stir well to obtain the mixed extract C (concentration 2g/ml);

(5)将步骤(4)制取的浸膏采用口服方式服用,一天两次,早上8:00-8:30灌胃一次,下午4:00-4:30灌胃一次,连续服用14天。(5) Take the extract prepared in step (4) orally, twice a day, once at 8:00-8:30 in the morning, and once at 4:00-4:30 in the afternoon, for 14 consecutive days .

实施例6:Embodiment 6:

一种使用黄芪复方药物修复神经损伤治疗方法,黄芪复方药物由以下重量份的原料制备而成:黄芪65份、党参4份、红花3份、川芎3份、茯苓2份、白芷5份、羌活1份、厚朴1份、白术2份、生地黄1份、柴胡1份、香附2份、莱菔子1份、黄芩6份。The invention discloses a method for treating nerve damage by using a compound medicine of Astragalus membranaceus. The compound medicine of Astragalus membranaceus is prepared from the following raw materials in parts by weight: 65 parts of Astragalus membranaceus, 4 parts of Codonopsis pilosula, 3 parts of safflower, 3 parts of Rhizoma Chuanxiong, 2 parts of Poria cocos, 5 parts of Angelica dahurica, Notopterygium 1 part, Magnolia officinalis 1 part, Atractylodes macrocephala 2 parts, Rehmannia glutinosa 1 part, Bupleurum 1 part, Cyperus cyperi 2 parts, radish seed 1 part, Scutellaria baicalensis 6 parts.

其治疗方法为:Its treatment method is:

(1)首先按处方重量份数称取茯苓与莱菔子混合,粉碎成极细粉(全部通过9号筛200目),得混合粉末A;(1) firstly take Poria cocos and raisin seed and mix by weight parts of the prescription, be ground into very fine powder (all pass through No. 9 sieve 200 meshes), get mixed powder A;

(2)按处方重量份数称取香附,粉碎后过2号至3号筛,将该粉末置挥发油提取器中,加入适量水,浸泡6小时,连续回流提取10小时,收集挥发油;(2) Cyperi cyperi was weighed in parts by weight of the prescription, crushed and passed through No. 2 to No. 3 sieves, the powder was placed in a volatile oil extractor, an appropriate amount of water was added, soaked for 6 hours, continuously refluxed for 10 hours, and the volatile oil was collected;

(3)按处方重量份数称取其余11味药材,分别单独粉碎,混合得总粉,加入相对浓度为70%的乙醇溶液,加热回流提取8小时,冷却,过滤去除滤渣得滤液,滤液回收乙醇得浓缩浸膏B;(3) Weigh the remaining 11 medicinal materials according to the weight of the prescription, grind them separately, mix to obtain the total powder, add ethanol solution with a relative concentration of 70%, heat and reflux for extraction for 8 hours, cool, filter and remove the filter residue to obtain the filtrate, and recover the filtrate Ethanol to obtain concentrated extract B;

(4)最后将香附挥发油加入浓缩浸膏B中搅拌均匀50min,再将混合粉末A加入浓缩浸膏B中,充分搅拌均匀,得混合浸膏C(浓度2g/ml);(4) Finally, add Cyperus cyperi volatile oil into the concentrated extract B and stir evenly for 50 minutes, then add the mixed powder A into the concentrated extract B, and stir well to obtain the mixed extract C (concentration 2g/ml);

(5)将步骤(4)制取的浸膏采用口服方式服用,一天两次,早上8:00-8:30灌胃一次,下午4:00-4:30灌胃一次,连续服用14天。(5) Take the extract prepared in step (4) orally, twice a day, once at 8:00-8:30 in the morning, and once at 4:00-4:30 in the afternoon, for 14 consecutive days .

疗效观察:Curative effect observation:

方法:雌性Wistar大鼠60只,建立双侧大鼠坐骨神经钳夹伤(止血钳闭合第二齿)模型,随机分为高剂量组(A组)、中剂量组(B组)、低剂量组(C组)和空白对照组(D组)。分别腹腔2ml/d,1ml/d,0.5ml/d药物和2ml/d生理盐水。连续给药28天。术后4、6、8周分别进行大体观察,测定再生神经的神经电图,组织学和透射电镜观察,分析靶器官的形态变化并采用免疫组化染色等方法评估坐骨神经再生质量和功能恢复情况。Methods: 60 female Wistar rats were established with bilateral sciatic nerve clamp injury (hemostatic forceps closing the second tooth) model, and randomly divided into high-dose group (group A), middle-dose group (group B) and low-dose group (Group C) and blank control group (Group D). Respectively intraperitoneal 2ml/d, 1ml/d, 0.5ml/d drug and 2ml/d saline. Continuous administration for 28 days. At 4, 6, and 8 weeks after operation, the general observation was performed, the electroneurogram of the regenerated nerve was measured, histological and transmission electron microscope observations were performed, the morphological changes of the target organs were analyzed, and the regeneration quality and functional recovery of the sciatic nerve were evaluated by immunohistochemical staining and other methods .

结果:(1)神经电生理:术后4、6、8周各时间点再生神经的运动神经传导速度、动作电位波幅随时间延长而增大,纵向比较各时间点两项指标数值总体呈A>B>C>D,但A组与B组,C组与D组相比差异没有统计学意义(P>0.05);A组、B组与D组相比,B组与C组相比差异有显著意义(P<0.05)。(2)术后8周神经HE染色观察:见各组再生神经均跨越吻合口向远端生长,缝线眼周围炎细胞不同程度浸润。A组有髓经纤维粗细均匀,排列整齐,轴索髓鞘较完整,神经再生较成熟;B组有髓神经纤维稍细,排列稍松散。C组神经纤维多为有髓神经纤维,神经纤维稍细,排列稍松散。D组神经纤维排列松散,部分神经纤维未见轴索及髓鞘。神经亚甲基蓝-碱性复红染色见A、B组有髓神经纤维平均直径和髓鞘厚度较均一,髓鞘形状规则,束间结缔组织少;C、D组有髓神经纤维平均直径和髓鞘厚度不一,髓鞘形状不规则,结缔组织增生明显(×40)。Results: (1) Nerve electrophysiology: The motor nerve conduction velocity and action potential amplitude of the regenerated nerve at each time point after 4, 6, and 8 weeks increased with time, and the values of the two indicators at each time point were generally A in the longitudinal comparison. >B>C>D, but there was no significant difference between group A and group B, group C and group D (P>0.05); group A, group B and group D, group B and group C The difference was significant (P<0.05). (2) Observation of nerve HE staining at 8 weeks after operation: It can be seen that the regenerated nerves in each group grew across the anastomosis to the distal end, and inflammatory cells infiltrated around the sutured eyes to varying degrees. The myelinated nerve fibers in group A were uniform in thickness and arranged neatly, the axonal myelin sheath was relatively complete, and the nerve regeneration was more mature; the myelinated nerve fibers in group B were slightly thinner and arranged loosely. Most of the nerve fibers in group C were myelinated nerve fibers, the nerve fibers were slightly thinner, and the arrangement was slightly loose. In group D, the nerve fibers were loosely arranged, and some nerve fibers had no axons and myelin sheaths. Nerve methylene blue-basic fuchsin staining shows that the average diameter of myelinated nerve fibers and myelin sheath thickness in groups A and B are relatively uniform, the shape of myelin sheath is regular, and there is less interfascicular connective tissue; the average diameter of myelinated nerve fibers and myelin sheath in groups C and D The thickness is different, the shape of myelin sheath is irregular, and the hyperplasia of connective tissue is obvious (×40).

(3)术后8周透射电镜观察:显示A、B、C组再生神经纤维数目多,神经纤维粗大,轴索髓鞘比基本达1:1,髓鞘较厚,板层致密,明暗板清晰,结构成熟度较均一。D组再生神经纤维直径差异较大,髓鞘较薄,形状不规则,扭曲变形明显,板层疏松,成熟度欠佳,其间散在新生无髓神经纤维。(3) Observation by transmission electron microscope at 8 weeks after operation: the number of regenerated nerve fibers in groups A, B, and C is large, the nerve fibers are thick, the ratio of axon to myelin sheath is basically 1:1, the myelin sheath is thicker, the lamellar layer is dense, and the light and dark plate Clear, relatively uniform structural maturity. The diameter of the regenerated nerve fibers in group D was quite different, the myelin sheath was thin, the shape was irregular, the distortion was obvious, the lamellar layer was loose, the maturity was not good, and new unmyelinated nerve fibers were scattered among them.

(4)术后12周小腿三头肌HE染色观察:A、B组肌细胞排列整齐,较紧密,横截面积大,肌纤维较粗,B组肌纤维间的间隙宽于A组。C组肌纤维粗细不一,肌纤维间的间隙较宽,有结缔组织增生;D组萎缩的肌纤维呈明显角状,呈小簇状分布在肌束内,深染的细胞核增多,肌纤维横截面积小,肌纤维间的间隙增宽,结缔组织增生较多。各组鼠小腿三头肌TSCI和肌纤维横截面积两两相比,A组、B组与D组相比,B组与C组相比差异有显著意义(P<0.05);A组与B组相比,C组与D组相比差异没有显著意义(P>0.05)。(4) HE staining observation of triceps calf muscle at 12 weeks after operation: the muscle cells in groups A and B were neatly arranged, relatively compact, with large cross-sectional area and thick muscle fibers, and the gap between muscle fibers in group B was wider than that in group A. In group C, the muscle fibers are of different thickness, the gap between muscle fibers is wide, and there is hyperplasia of connective tissue; in group D, the atrophic muscle fibers are obviously horn-shaped, distributed in small clusters in the muscle bundle, with more deeply stained nuclei, and the cross-sectional area of muscle fibers is small , the gap between muscle fibers widened, more connective tissue hyperplasia. The triceps calf muscle TSCI and cross-sectional area of muscle fibers in each group were compared in pairs, group A, group B were compared with group D, and group B was significantly different from group C (P<0.05); There was no significant difference between group C and group D (P>0.05).

(5)免疫组织化学染色:术后4周再生神经NGF蛋白表达量各组两两比较差异有显著性(P<0.05);各组微血管计数两两相比,A组、B组与D组相比,B组与C组相比差异有显著意义(P<0.05);A组与B组相比,C组与D组相比差异没有显著意义(P>0.05)。(5) Immunohistochemical staining: 4 weeks after operation, there was a significant difference in the expression of NGF protein in the regenerated nerve between each group (P<0.05); Compared with group B, there was a significant difference between group C (P<0.05); compared with group A, there was no significant difference between group C and group D (P>0.05).

经过疗效观察可知,本发明使用黄芪复方药物修复神经损伤治疗方法,效果好,见效快,经灌胃后两个月对大鼠复查统计,无感染且较快恢复正常步态运动,无不良反应。Through curative effect observation, it can be seen that the present invention uses Astragalus compound medicine to repair nerve damage treatment method, which has good effect and quick effect, and the rats are rechecked and counted two months after gavage, and there is no infection, and the normal gait movement is quickly restored, and there is no adverse reaction. .

以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: it can still be described in the foregoing embodiments Modifications are made to the recorded technical solutions, or equivalent replacements are made to some of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims (6)

1. one kind uses Huangqi Compound medicine repairing nerve damage Therapeutic Method, it is characterised in that described Huangqi Compound medicine It is prepared from by the raw material of following weight portion: Radix Astragali 50-70 part, Radix Codonopsis 3-10 part, Flos Carthami 3-10 part, Rhizoma Chuanxiong 3-10 part, Poria 2-10 part, Radix Angelicae Dahuricae 10-15 part, Rhizoma Et Radix Notopterygii 1-5 part, Cortex Magnoliae Officinalis 1-5 part, Rhizoma Atractylodis Macrocephalae 2-11 part, Radix Rehmanniae 1-8 part, Radix Bupleuri 1-6 part, Rhizoma Cyperi 2-3 part, Semen Raphani 1-8 part, Radix Scutellariae 2-6 part;
Its Therapeutic Method is:
(1) first weigh Poria by prescription parts by weight to mix with Semen Raphani, be ground into impalpable powder (all by No. 9 sieves 200 Mesh), obtain mixed-powder A;
(2) weigh Rhizoma Cyperi by prescription parts by weight, cross No. 2 to No. 3 sieves after pulverizing, this powder is put in volatile oil extractor, adds Enter suitable quantity of water, soak 5-6 hour, continuous circumfluence extraction 9-12 hour, collect volatile oil;
(3) weigh remaining 11 taste medical material by prescription parts by weight, individually pulverize, mix to obtain total powder, add ethanol in proper amount molten Liquid, heating and refluxing extraction 5-8 hour, cooling, filter removal filtering residue and obtain filtrate, filtrate recycling ethanol obtains concentrated extract B;
(4) finally Rhizoma Cyperi volatile oil is added in concentrated extract B and stirs, then mixed-powder A is added in concentrated extract B, Stir, extractum C (concentration 2g/ml) must be mixed;
(5) extractum step (4) produced uses oral way to take, one day twice, morning 8:00-8:30 gavage once, under Noon 4:00-4:30 gavage once, takes 14 days continuously.
2. use Huangqi Compound medicine repairing nerve damage Therapeutic Method as claimed in claim 1, it is characterised in that described Huangqi Compound medicine is prepared from by the raw material of following weight portion: Radix Astragali 55-68 part, Radix Codonopsis 4-8 part, Flos Carthami 3-10 part, Rhizoma Chuanxiong 4-9 part, Poria 3-8 part, Radix Angelicae Dahuricae 10-15 part, Rhizoma Et Radix Notopterygii 2-4 part, Cortex Magnoliae Officinalis 2-4 part, Rhizoma Atractylodis Macrocephalae 4-10 part, Radix Rehmanniae 2-6 part, Radix Bupleuri 2- 5 parts, Rhizoma Cyperi 2-3 part, Semen Raphani 2-7 part, Radix Scutellariae 2-6 part.
3. use Huangqi Compound medicine repairing nerve damage Therapeutic Method as claimed in claim 2, it is characterised in that described Huangqi Compound medicine is prepared from by the raw material of following weight portion: the Radix Astragali 55 parts, Radix Codonopsis 4 parts, 4 parts of Flos Carthami, Rhizoma Chuanxiong 5 parts, Poria 4 Part, the Radix Angelicae Dahuricae 5 parts, Rhizoma Et Radix Notopterygii 3 parts, Cortex Magnoliae Officinalis 2 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, Radix Rehmanniae 3 parts, Radix Bupleuri 2 parts, Rhizoma Cyperi 3 parts, Semen Raphani 3 parts, Radix Scutellariae 3 Part.
4. use Huangqi Compound medicine repairing nerve damage Therapeutic Method as claimed in claim 2, it is characterised in that described Huangqi Compound medicine is prepared from by the raw material of following weight portion: the Radix Astragali 68 parts, Radix Codonopsis 5 parts, 3 parts of Flos Carthami, Rhizoma Chuanxiong 6 parts, Poria 5 Part, the Radix Angelicae Dahuricae 6 parts, Rhizoma Et Radix Notopterygii 2 parts, Cortex Magnoliae Officinalis 2 parts, the Rhizoma Atractylodis Macrocephalae 7 parts, Radix Rehmanniae 1 part, Radix Bupleuri 3 parts, Rhizoma Cyperi 2 parts, Semen Raphani 3 parts, Radix Scutellariae 3 Part.
5. use Huangqi Compound medicine repairing nerve damage Therapeutic Method as claimed in claim 1, it is characterised in that described In preparation method step (3), the relative concentration of ethanol solution is 70%.
6. use Huangqi Compound medicine repairing nerve damage Therapeutic Method as claimed in claim 1, it is characterised in that described The uniform stirring time in preparation method step (4) is 30-50min.
CN201610938402.5A 2016-10-25 2016-10-25 A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method Pending CN106266408A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610938402.5A CN106266408A (en) 2016-10-25 2016-10-25 A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610938402.5A CN106266408A (en) 2016-10-25 2016-10-25 A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method

Publications (1)

Publication Number Publication Date
CN106266408A true CN106266408A (en) 2017-01-04

Family

ID=57719896

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610938402.5A Pending CN106266408A (en) 2016-10-25 2016-10-25 A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method

Country Status (1)

Country Link
CN (1) CN106266408A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107412505A (en) * 2017-09-06 2017-12-01 王维维 A kind of Chinese medicine combination drug for treating fatty liver
CN110269874A (en) * 2019-08-02 2019-09-24 陇东学院 A kind of rush nerve regneration drug
EP4082556A4 (en) * 2020-07-20 2023-07-26 Nantong University PREPARATION OF COMPOUND FOR NERVOUS TISSUE REGENERATION, METHOD FOR PREPARATION AND USE

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102091166A (en) * 2009-12-15 2011-06-15 复旦大学附属华山医院 Compound preparation for promoting neuromuscular regeneration and preparation method thereof
CN105125788A (en) * 2015-08-06 2015-12-09 马少川 Nerve injury recovery powder
CN105596978A (en) * 2015-12-23 2016-05-25 薛学明 Drug for treating nerve injury and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102091166A (en) * 2009-12-15 2011-06-15 复旦大学附属华山医院 Compound preparation for promoting neuromuscular regeneration and preparation method thereof
CN105125788A (en) * 2015-08-06 2015-12-09 马少川 Nerve injury recovery powder
CN105596978A (en) * 2015-12-23 2016-05-25 薛学明 Drug for treating nerve injury and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
汪宝军等: "理气补血汤对周围神经再生影响的实验研究", 《中医正骨》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107412505A (en) * 2017-09-06 2017-12-01 王维维 A kind of Chinese medicine combination drug for treating fatty liver
CN110269874A (en) * 2019-08-02 2019-09-24 陇东学院 A kind of rush nerve regneration drug
EP4082556A4 (en) * 2020-07-20 2023-07-26 Nantong University PREPARATION OF COMPOUND FOR NERVOUS TISSUE REGENERATION, METHOD FOR PREPARATION AND USE
US12115204B2 (en) 2020-07-20 2024-10-15 Nantong University Compound preparation for neuranagenesis, and preparation method therefor and use thereof

Similar Documents

Publication Publication Date Title
CN1330347C (en) Gongbu ointment
CN104922543A (en) Medicine composite for treating amenorrhea and preparation method thereof
CN106266408A (en) A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method
CN104524159A (en) Pharmaceutical composition for treating hyperplasia of mammary glands
CN104383515A (en) Chinese medicinal composition for treating postpartum rheumatism due to deficiency of qi and blood
CN104225166A (en) Chinese medicine composition for treating amenorrhea and preparation method thereof
CN106237010A (en) The compound medicine of a kind of repairing nerve damage with the Radix Astragali as principal agent and preparation method
CN104225507A (en) Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage
CN104523873A (en) Pharmaceutical composition for treating gout
CN103690875A (en) Traditional Chinese medicinal preparation for treating aplastic anemia
CN114748603A (en) A medicine and food homologous composition and application for preventing and treating new coronavirus pneumonia mutation or rejuvenation
CN104840773A (en) Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same
CN107617081B (en) Traditional Chinese medicine composition for treating alopecia and preparation method thereof
CN105343688A (en) Medicine composition for treating myocardial infarction and application thereof
CN110694037A (en) A composition for treating cervical spondylosis, cold and depression
CN105213748A (en) A pharmaceutical composition for treating climacteric syndrome in women and its preparation method
CN105853866A (en) Method for preparing Chinese herbal medicine composition for treating bedsore
CN103735741A (en) Traditional Chinese medicinal composition for treating gout
CN105998512A (en) Pharmaceutical composition for the treatment of femoral shaft fracture and preparation method thereof
CN115487264A (en) Composition for reducing phlegm and removing stasis and preparation method thereof
CN105362933A (en) Application of artemisia argyi-containing pharmaceutical composition in preparation of drug for treatment of amenorrhoea
CN104922595A (en) Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof
CN105412736B (en) Oral Chinese herbal medicine for treating breast fibroadenoma and preparation method thereof
CN119326837A (en) A Chinese medicine composition with the effects of promoting blood circulation and removing blood stasis, warming meridians and unblocking collaterals, and its preparation method, application and product
CN104645247A (en) Traditional Chinese medicine preparation for treating hepatolenticular degeneration and preparation method of traditional Chinese medicine preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170104

RJ01 Rejection of invention patent application after publication